Population pharmacokinetics of bevacizumab in cancer patients with external validation
about
Population pharmacokinetics of bevacizumab in cancer patients with external validation
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Population pharmacokinetics of bevacizumab in cancer patients with external validation
@ast
Population pharmacokinetics of bevacizumab in cancer patients with external validation
@en
Population pharmacokinetics of bevacizumab in cancer patients with external validation
@nl
type
label
Population pharmacokinetics of bevacizumab in cancer patients with external validation
@ast
Population pharmacokinetics of bevacizumab in cancer patients with external validation
@en
Population pharmacokinetics of bevacizumab in cancer patients with external validation
@nl
prefLabel
Population pharmacokinetics of bevacizumab in cancer patients with external validation
@ast
Population pharmacokinetics of bevacizumab in cancer patients with external validation
@en
Population pharmacokinetics of bevacizumab in cancer patients with external validation
@nl
P2093
P2860
P3181
P1476
Population pharmacokinetics of bevacizumab in cancer patients with external validation
@en
P2093
David E Allison
Kelong Han
Mathilde Marchand
Nathalie H Gosselin
Sandhya Girish
Thomas Peyret
P2860
P2888
P304
P3181
P356
10.1007/S00280-016-3079-6
P407
P577
2016-06-21T00:00:00Z
P6179
1013715798